ArticleACS medicinal chemistry letters2025

Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors as Potential Treatment for Several Inflammatory and Neurodegenerative Diseases.

Ahmed F Abdel-MagidPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.